£80.09

Springer p53 in the Clinics

Name: p53 in the Clinics
Brand: Springer
Price: 79.93 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 37 days • 37 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price

Price Analysis

Most common price: £80 (37 days, 100.0%)

Price range: £80 - £80

Price levels: 1 different prices over 37 days

Description

Product Description Building on the success of the 2006 book "25 years of p53", this book reviews the uses of p53 as a key tumor suppressor and component of novel cancer therapy and details considerable advances in the potential application of p53 into the clinics. From the Back Cover With over 60,000 referenced publications, p53 has emerged as one of the most important factors in human cancer. Research on p53 has led to a complete overhaul of our understanding of the molecular basis of human cancer. In recent years, these major advances in knowledge are starting to impact on cancer management and therapy. This book thus captures a critical turning point in p53 research, from basic to translational research and clinical application. p53 in the Clinics follows the success of 25 Years of p53 Research and condensates in a series of authoritative chapters the considerable progress on the applications of p53 into the clinics and the substantial advances on diseases caused by inheritance of p53 defects, on somatic p53 mutations as biomarkers in molecular pathology, on progress in gene therapy and on developments of innovative drugs and clinical trials. This volume will appeal to a wide audience of students and professionals in basic and clinical cancer research and treatment, and will highlight the exciting “next steps” in p53 research and applications.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1489992170
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 19 September 2014
Listed Since: 20 September 2014

Barcode

No barcode data available

Springer p53 in the Clinics

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - 25 Years of p53 Research - Cancer Therapy Book

Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85

Springer - The p53 Tumor Suppressor Pathway and Cancer 2

Molecular Biology of Human Cancers

Molecular Biology of Human Cancers

Oncogenes and Tumor Suppressor Genes in Human Malignancies: 63 (Cancer Treatment and Research, 63)

Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)

Cancer Genomics: Molecular Classification, Prognosis and Response Prediction

Cancer Genetics: 155 (Cancer Treatment and Research, 155)

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Origin of Cancers: Clinical Perspectives and Implications of a Stem-Cell Theory of Cancer: 154 (Cancer Treatment and Research, 154)

Springer - Molecular Genetics of Pancreatic Cancer Book

Cancer Genome and Tumor Microenvironment (Cancer Genetics)

Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics

The Hereditary Basis of Childhood Cancer

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)

MicroRNAs: Key Regulators of Oncogenesis

Springer - Pharmacogenetics: Making Cancer Treatment Safer

New Developments in Metastasis Suppressor Research